|
R&D Systems
recombinant cd161  Recombinant Cd161, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+cd161/pm26829983-85-3-5?v=R%26D+Systems Average 90 stars, based on 1 article reviews
recombinant cd161 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Killer cell lectin-like receptor subfamily B, member 1(KLRB1) is a single-pass type II membrane protein which contains 1 C-type lectin domain. KLRB1 plays an inhibitory role on natural killer (NK) cells cytotoxicity. Activation results in
|
Buy from Supplier |
|
The Recombinant Human CD161 Protein has been validated for the following applications SDS Page
|
Buy from Supplier |
|
CD161 Recombinant Protein Antigen
|
Buy from Supplier |
|
Human CD161 Recombinant Protein expressed in Baculovirus with hIgG-His-tag. Sequence domain: 67-225aa. Application(s): SDS-PAGE. Endotoxin: < 1 EU per 1ug of protein (determined by LAL method).
|
Buy from Supplier |
Image Search Results
Journal: Journal of immunology (Baltimore, Md. : 1950)
Article Title: LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation.
doi: 10.4049/jimmunol.1502462
Figure Lengend Snippet: FIGURE 4. CD161 is expressed on FDCs and on a subset of tonsillar T cells. (A) CD161 expression nega- tively correlated with CXCR5 ex- pression on CD45RA2 T cells (CD3+
Article Snippet: For LLT1 crosslinking,
Techniques: Expressing
Journal: Journal of immunology (Baltimore, Md. : 1950)
Article Title: LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation.
doi: 10.4049/jimmunol.1502462
Figure Lengend Snippet: FIGURE 5. LLT1 promotes B cell activation. (A) Purified B cells from PBMCs were stimulated with anti-BCRs only or with anti-BCRs with and without rCD161 or IC. Geometric mean fluorescence intensities (GeoMFI) of CD83 and CD38 were measured by flow cytometry. B cell stimulation with rCD161 resulted in enhanced levels of CD83 and CD38; data were pooled from three independent experiments (n = 7, **p , 0.01). (B) Tonsillar cells were cultured for 3 d with CpG or anti-CD40 plus IL-4. Blocking LLT1–CD161 interaction resulted in a decreased expression of CD83 and CD38 on B cells; data were pooled from four independent experiments (n = 12, ****p , 0.0001). (C) Depletion of CD161+ cells from tonsillar cells resulted in decreased expression of CD83 (anti-CD40 plus IL-4 stimulation) and CD38 (CpG stimulation) on B cells after 3 d; data were pooled from two independent experiments (n = 8; *p , 0.05, ****p , 0.0001, paired t test). (D) Overnight stimulation of tonsillar B cells with rCD161 or 2H7 anti-LLT1 Ab did not change the expression of CD83 on GC B cells (n = 5). (E) However, a decrease in CXCR4 expression levels was observed GC B cells (n = 10; **p , 0.01, ****p , 0.0001). (F) Repeated experiments on sorted DZ B cells revealed a downregulation of CXCR4 mRNA. All statistics were two-way ANOVA using a Bonferroni multiple comparisons test, unless stated otherwise.
Article Snippet: For LLT1 crosslinking,
Techniques: Activation Assay, Cytometry, Cell Stimulation, Cell Culture, Blocking Assay, Expressing